Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1) (Q35879088)
Jump to navigation
Jump to search
scientific article published in February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1) |
scientific article published in February 2012 |
Statements
1 reference
Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1) (English)
1 reference
Itamar Raz
1 reference
Vivian Fonseca
1 reference
Mark Kipnes
1 reference
Laurence Durrwell
1 reference
John Hoekstra
1 reference
Mark Boldrin
1 reference
Raffaella Balena
1 reference
1 February 2012
1 reference
1 reference
485-487
1 reference
Identifiers
1 reference
1 reference
1 reference